Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Laboratory of Molecular Psychiatry, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA (США)
Список исп. литературыСкрыть список 1. Krystal J, Sanacora G, Duman RS. Rapid-acting glutamatergic antidepressants:the path to ketamine and beyond. Biol Psychiatry 2013; 73: 1133–41. 2. Duman R, Aghajanian GK. Synaptic dysfunction in depression: novel therapeutic targets. Science 2012; 338: 68–72. 3. Li N, Lee BY, Liu RJ et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959–64. 4. Homayoun H, Moghaddam B. NMDA-receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 2007; 27: 11 496–500. 5. Dwyer JM, Duman RS. Unpublished data. 6. Liu R-J, Fuchikami M, Dwyer JM et al. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology (in press). 7. Drevets W, Furey ML. Replication of scopolamine’s antidepressant efficacy in major depressive disorder: a randomized, placebocontrolled clinical trial. Biol Psychiatry 2010; 67: 432–8. 8. Voleti B, Navarria A, Liu R-J et al. Scopolamine rapidly increases mTORC1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry (in press). 9. Iwata M, Ota KT, Duman RS.The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 2013; 31: 105–14. 10. Chaudhury D, Walsh JJ, Friedman AK et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013; 493: 532–6. 11. Chung K, Wallace J, Kim SY et al. Structural and molecular interrogation of intact biological systems. Nature 2013; 497: 332–7.